Patient’s baseline, presentation and 1-month follow-up labs
Investigation | Normal range | Baseline | Presentation | 1-month follow-up |
Complete Blood Count | ||||
Red cell count | 4.0–5.2 x1012/L | 3.37 | 2.66 | 3.22 |
White cell count | 4.5–11.0x109/L | 2.46 | 2.77 | 2.80 |
Haemoglobin | 120–150 g/L | 110 | 87 | 97 |
Platelets | 150.0–350.0x109/L | 131 | 146 | 290 |
Absolute Neutrophil Count | 1.5–7.80x109/L | 1.24 | 1.44 | 1.97 |
Mean Corpuscular Volume | 80.0–100.0 fL | 100.3 | 96.6 | 95.0 |
Complete Metabolic Panel | ||||
Na | 135–143 mmol/L | 142 | 140 | 141 |
K | 3.6–5.0 mmol/L | 4.6 | 4.1 | 4.6 |
Cl | 98–107 mmol/L | 107 | 105 | 104 |
HCO3 | 23–27 mmol/L | 30 | 24 | 26 |
BUN | 7–20 mg/dL | 34 | 35 | 28 |
Cr | 0.5–1.6 mg/dL | 1.0 | 0.8 | 0.9 |
Alb | 3.5–5.5 g/dL | 4.3 | 3.1 | 3.8 |
Bili | <1.2 mg/dL | <0.2 | <0.2 | 0.4 |
Alk phos | 33–147 µ(IU)/L | 79 | 64 | 80 |
Aspartate Aminotransferase | 8–33 U/L | 15 | 18 | 14 |
Alanine Transaminase | 7–55 U/L | 11 | 20 | 25 |
Glucose | 71–99 mg/dL | 91 | 149 | 112 |
Additional studies | ||||
Brain Natriuretic Peptide | 20–127 pg/mL | 194 | 356 | 248 |
Erythrocyte Sedimentation Rate | 0–30 mm/hour | 49 | 126 | 108 |
C-Reactive Protein | 0.15–5.0 mg/L | 2.4 | 6.9 | 2.3 |
Thyroid studies | ||||
Thyroid Stimulating Hormone | 0.35–2.00 µ(IU)/mL | 1.18 | <0.02 | <0.02 |
Free T4 | 0.9–1.7 ng/dL | 1.4 | 7.2 | 1.3 |
Total T3 | 0.8–2.8 ng/mL | 1.1 | 5.3 | 1.3 |
Thyroid stimulating immunoglobulin | <140% baseline | – | 347 | 438 |
Thyroid peroxidase | 0–9.0 IU/mL | – | 8.9 | 8.6 |
– shows lab value was not obtained or no value was available per patient records.